| 1/4 | US=84 / Biol/Mol Xu L. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: ski, snoN, and aKt as negative regulators of smad activity: balancing cell death and cell survival regulatorsnuclear targeting of TGF-B-activated smads in normal and tumor biology. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 139-53. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. |
| 2/4 | US=84 / Biol/Mol Band A, Laiho M. Basic concepts of TGF-B signaling in normal physiology and cancer pathobiology: transforming growth factor-B in cancer therapy. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 243-57. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TGF-BETA; SMAD; TRANSDUCAO DE SINAL; SNON; PROTEASSOMA; UBIQUITINA; SUMO; DEGRADACAO |
| 3/4 | US=84-A / Biol/Mol Wilkinson DS, Barton MC. Transformig growth factor-B in developing and advanced cancers: tumor suppressors p53 and TGFB converge to regulate the alpha-fetoprotein oncodevelopmental tumor marker. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 309-20. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 4/4 | US=84-A / Biol/Mol Wilkinson DS, Barton MC. Transformig growth factor-B in developing and advanced cancers: tumor suppressors p53 and TGFB converge to regulate the alpha-fetoprotein oncodevelopmental tumor marker. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 309-20. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |